Skip to main content
Professional Technical IVT

GVHD

Also written as: GVHD — Graft-Versus-Host Disease

Graft-versus-host disease, a complication of stem cell transplantation where donor cells attack recipient tissues.

Full Definition

Graft-versus-host disease (GVHD) is a potentially life-threatening complication following allogeneic hematopoietic stem cell transplantation where donor immune cells recognize recipient tissues as foreign and mount an immune attack. GVHD is classified as acute (typically occurring within 100 days) or chronic (beyond 100 days or with chronic features). Acute GVHD commonly affects skin, gastrointestinal tract, and liver, while chronic GVHD can affect multiple organ systems. Prevention typically involves immunosuppressive prophylaxis, and treatment requires careful balance between controlling GVHD and maintaining graft-versus-tumor effects.

Usage

Usage note: Grading systems differ for acute versus chronic GVHD.

In Context

  • "The patient developed grade II acute GVHD affecting skin and GI tract." — Post-transplant monitoring note
  • "Chronic GVHD prophylaxis includes cyclosporine and methotrexate." — Transplant protocol

Also known as

graft-versus-host disease

Contrasted with

graft acceptance immunologic tolerance

Don't confuse with

graft rejection infection complications

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON